Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.
The metabolic phenotype of the failing heart includes a decrease in phosphocreatine and total creatine concentration [Cr], potentially contributing to contractile dysfunction. Surprisingly, in 32- week-old mice over-expressing the myocardial creatine transporter (CrT-OE), we previously demonstrated...
Main Authors: | Phillips, D, Ten Hove, M, Schneider, J, Wu, C, Sebag-Montefiore, L, Aponte, A, Lygate, C, Wallis, J, Clarke, K, Watkins, H, Balaban, R, Neubauer, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Regulation of Myocardial Creatine Uptake by Intra- and Extracellular Creatine Levels
by: Makinen, K, et al.
Published: (2008) -
Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction.
by: Lygate, C, et al.
Published: (2012) -
Supernormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure - Insights from creatine transporter over-expression transgenic mice
by: Wallis, J, et al.
Published: (2005) -
The creatine kinase energy transport system in the failing mouse heart.
by: Lygate, C, et al.
Published: (2007) -
Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice.
by: Wallis, J, et al.
Published: (2005)